Literature DB >> 30685866

Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland.

Henryk Zulewski1, Luca Giovanella2, Stefan Bilz3, Emanuel Christ4, Andreas Haldemann5, Hans Steinert6, Sabine Weidner7, Daniel Oertli8, Frédéric Triponez9, Thomas Clerici10, Anna Minder11, Matthias Dettmer12, Paul Komminoth13.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30685866     DOI: 10.4414/smw.2019.14700

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


× No keyword cloud information.
  5 in total

1.  Variations in radioiodine ablation: decision-making after total thyroidectomy.

Authors:  O Maas; F Forrer; M Maas; C M Panje; J Blautzik; M Brühlmeier; I Engel-Bicik; L Giovanella; A Haldemann; M E Kamel; S Kneifel; C Rottenburger; N Schaefer; M A Walter; S Weidner; P M Putora
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-09       Impact factor: 9.236

2.  Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy.

Authors:  Flavio Forrer; Galina Farina Fischer; Ole Maas; Luca Giovanella; Martha Hoffmann; Ioannis Iakovou; Markus Luster; Jasna Mihailovic; Petra Petranovic Ovčariček; Alexis Vrachimis; Slimane Zerdoud; Paul Martin Putora
Journal:  Oncology       Date:  2021-11-17       Impact factor: 2.935

Review 3.  Total thyroidectomy vs. lobectomy in differentiated thyroid cancer: is there a reasonable size cut-off for decision? A narrative review.

Authors:  Daniele Barbaro; Giancarlo Basili; Gabriele Materazzi
Journal:  Gland Surg       Date:  2021-07

Review 4.  Poorly differentiated thyroid carcinoma : An underdiagnosed entity.

Authors:  M S Dettmer; A Schmitt; P Komminoth; A Perren
Journal:  Pathologe       Date:  2020-06       Impact factor: 1.011

Review 5.  Personalized management of differentiated thyroid cancer in real life - practical guidance from a multidisciplinary panel of experts.

Authors:  Alfredo Campennì; Daniele Barbaro; Marco Guzzo; Francesca Capoccetti; Luca Giovanella
Journal:  Endocrine       Date:  2020-08-09       Impact factor: 3.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.